Table 2.
Case | Histological diagnosis | BRAF status | % of mutated reads | Total number of reads |
---|---|---|---|---|
11 | DNT | V600E | 16.6 | 883 |
NO FCD | WT | |||
12 | DNT | WT | ||
NO FCD | WT | |||
13 | PGNT | WT | ||
NO FCD | WT | |||
14 | Gangliocytoma | WT | ||
NO FCD | WT | |||
15 | PXA | V600E | 17.5 | 519 |
NO FCD | WT | |||
16 | Grade II diffuse astrocytoma | V600E | 31 | 1352 |
NO FCD | WT | |||
17 | GG | WT | ||
NO FCD | WT | |||
18 | GG | V600K | 26 | 630 |
NO FCD | WT | |||
19 | Gangliocytoma | WT | ||
NO FCD | WT | |||
20 | GG | WT | ||
NO FCD | WT |
DNT, dysembryoplastic neuroepithelial tumor; FCD, focal cortical dysplasia; GG, ganglioglioma; PGNT, papillary glioneuronal tumor; PXA, pleomorphic xanthoastrocytoma; WT, wild type.